Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma
{{output}}
T-cell and natural killer-cell lymphomas are a relatively rare and heterogeneous group of diseases that are difficult to treat and usually have poor outcomes. To date, therapeutic interventions are of limited efficacy and there is a pressing need to find bette... ...
